FDA Announces Emergency Authorization For Convalescent Plasma To Treat COVID-19
The FDA issued an emergency use authorization for the use of convalescent plasma to treat Covid-19 on Sunday, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."